Redeye briefly presents its key takeaways from BONESUPPORT’s capital markets day and reflects on the company’s updated financial targets for the coming years, which align with our forecasts. Our positive view of the case is strengthened following yesterday’s presentations, and we reiterate our SEK 77 Base Case.
LÄS MER
